Exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes-Reference-Cited by-同舟云学术

Exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes

Published:2022-11-19 Issue:3 Volume:66 Page:450-460
ISSN:0012-186X
Container-title:Diabetologia
language:en
Short-container-title:Diabetologia

Author:

Coomans de Brachène Alexandra^ORCID,Scoubeau Corentin,Musuaya Anyïshai E.,Costa-Junior Jose Maria,Castela Angela,Carpentier Julie,Faoro Vitalie,Klass Malgorzata,Cnop Miriam,Eizirik Decio L.

Funder

Innovative Medicines Initiative 2 Joint Undertaking

European Foundation for the Study of Diabetes

Dutch Diabetes Research Foundation

Walloon Region SPW-EERWin2Wal

JDRF and The Leona M. and Harry B. Helmsley Charitable Trust

INNOVIRIS BRIDGE

Francophone Foundation for Diabetes Research

Fonds De La Recherche Scientifique - FNRS

Welbio/FRFS

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00125-022-05837-9.pdf

Reference44 articles.

1. Eizirik DL, Pasquali L, Cnop M (2020) Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure. Nat Rev Endocrinol 16(7):349–362. https://doi.org/10.1038/s41574-020-0355-7

2. Eizirik DL, Szymczak F, Alvelos MI, Martin F (2021) From pancreatic β-cell gene networks to novel therapies for type 1 diabetes. Diabetes 70(9):1915–1925. https://doi.org/10.2337/dbi20-0046

3. Herold KC, Bundy BN, Long SA et al (2019) An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes. N Engl J Med 381(7):603–613. https://doi.org/10.1056/NEJMoa1902226

4. Sims EK, Bundy BN, Stier K et al (2021) Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals. Sci Transl Med 13(583):eabc8980. https://doi.org/10.1126/scitranslmed.abc8980

5. Marhfour I, Lopez XM, Lefkaditis D et al (2012) Expression of endoplasmic reticulum stress markers in the islets of patients with type 1 diabetes. Diabetologia 55(9):2417–2420. https://doi.org/10.1007/s00125-012-2604-3

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GDF15 is dispensable for the insulin-sensitizing effects of chronic exercise;Cell Reports;2024-08

2. Endoplasmic reticulum stress mechanisms and exercise intervention in type 2 diabetes mellitus;Biomedicine & Pharmacotherapy;2024-08

3. Training under normoxia and normobaric hypoxia in patients with type 1 diabetes;Endokrynologia Polska;2024-07-08

4. Prevalence and factors associated with thyroid autoimmunity among children newly diagnosed with type 1 diabetes before and during the COVID‐19 pandemic: Evidence from Kuwait;Diabetes/Metabolism Research and Reviews;2024-06-05

5. Advances in Exercise and Nutrition as Therapy in Diabetes;Diabetes Technology & Therapeutics;2024-03-01